Jay R. Venkatesan's Insider Trades & SAST Disclosures

Jay R. Venkatesan's most recent trade in Elicio Therapeutics Inc. was a trade of 7,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Elicio Therapeutics Inc.
Jay R. Venkatesan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 7,900 7,900 - - Stock Option (Right to Buy)
Elicio Therapeutics Inc.
Jay R. Venkatesan Director 26 Nov 2024 50,000 179,581 - 0.0 500 Common Stock
Elicio Therapeutics Inc.
Jay R. Venkatesan Director 26 Nov 2024 50,000 0 - - Warrant to Purchase Common Stock
Elicio Therapeutics Inc.
Jay R. Venkatesan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Elicio Therapeutics Inc.
Jay R. Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Elicio Therapeutics Inc.
Jay R. Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades